Media
News
Quotient Virtual Tour - Edinburgh, UK

Quotient Limited - CEO New Year's Message

 

 

Quotient Limited Wins 2021 BIG Innovation Award

JERSEY, Channel Islands, 12 January 2021(GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced it has been named a winner in the prestigious 2021 BIG Innovation Awards presented by the Business Intelligence Group.

Quotient Virtual Tour - Eysins, Switzerland

MosaiQ at Bloodworks Northwest Seattle, WA

Take an insider look at how our MosaiQ instrument is used at Bloodworks Northwest, and hear what a Bloodworks technologist and a donor have to say about our technology: 

Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody Test

JERSEY, Channel Islands, 28 September 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that on September 25, 2020, the U.S.

Quotient Limited to Publish Quarterly Investor Presentation

JERSEY, Channel Islands, August 4, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with the earnings call for fiscal quarter ended June 30, 2020.

Quotient Limited Reports First Quarter Fiscal 2021 Results and Business Update

•    Significant progress in three targeted areas of MosaiQ development – COVID-19 antibody test, potential new applications, and transfusion diagnostics 
•    Ten commercial placements of MosaiQ platform in Europe and the US

Quotient Announces Equity Awards

JERSEY, Channel Islands, 23 July 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced that Dr. Isabelle Buckle, Ph.D. and Dr. Catherine Larue, Ph.D.

Quotient Announces Appointment of Two New Board Members

JERSEY, Channel Islands, 23 July 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced changes in the composition of its board of directors that will take effect later this year.